| Long name: |
FITC Conjugated, ENTPD2/CD39L1 Polyclonal Antibody |
| Category: |
Conjugated Primary Antibodies |
| Conjugation: |
Anti-FITC Antibody |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
ENTPD2/CD39L1 |
| Specificity: |
This is a highly specific antibody against ENTPD2/CD39L1 |
| Modification: |
Unmodified |
| Modification site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Subcellular location: |
Extracellular |
| Source: |
KLH conjugated synthetic peptide derived from human ENTPD2/CD39L1 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Mouse, Rat, Human |
| Crossreactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: |
CD39 inhibits ADP-induced platelet aggregation by hydrolyzing ADP to AMP and ultimately generating adenosine, CD39L1 is a 495 amino acid multi-pass membrane protein that requires calcium and magnesium cofactors to hydrolyze ATP and other nucleotides in the regulation of purigenic neurotransmission, CD39L1 is expressed in kidney, Intracellular CD39 undergoes glycosylation at 6 N-glycosylation sites and translocates to the membrane in order to be an active enzyme, There are two isoforms of CD39L1 that are produced as a result of alternative splicing events, also known as ectonucleoside triphosphate diphosphohydrolase 1 (ENP1), brain, colon, heart, is an integral membrane glycoprotein that acts as an extracellular nucleotide-hydrolyzing enzyme, pancreas, prostate, skeletal muscle, small intestine and ovaries, testis, CD39 |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: |
494nm/518nm |
| Synonyms: |
NTPDase-2 |
| Properties: |
Bioss Primary Conjugated Antibodies FITC is highly sensitive to pH extremes, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This Bioss Primary Conjugated Antibodies Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
ENTPD2/CD39L1 Conjugated |
| Short name: |
FITC Conjugated, ENTPD2/CD39L1 Antibody |
| Technique: |
Fluorescein, antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: |
FITC |
| Alternative name: |
fluorecein coupled, ectonucleoside triphosphate diphosphohydrolase 2/CD39L1 (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CD39L1 and NTPDase-2, ENTPD2 and IDBG-641330 and ENSBTAG00000048125 and 100126045, ENTPD2 and IDBG-93039 and ENSG00000054179 and 954, Entpd2 and IDBG-145500 and ENSMUSG00000015085 and 12496, Plasma membranes, nucleoside-triphosphatase activity, this GO :0005515 and protein binding and molecular function this GO :0005524 and ATP binding and molecular function this GO :0005605 and basal lamina and cellular component this GO :0005789 and endoplasmic reticulum membrane and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0009181 and purine ribonucleoside diphosphate catabolic process and biological process this GO :0016021 and integral component of membrane and cellular component this GO :0016787 and hydrolase activity and molecular function this GO :0017110 and nucleoside-diphosphatase activity and molecular function this GO :0017111 and nucleoside-triphosphatase activity and molecular function this GO :0030168 and platelet activation and biological process, this GO :0005515 : protein binding, this GO :0005515 : protein binding and also this GO :0005524 : ATP binding and also this GO :0016787 : hydrolase activity and also this GO :0017110 : nucleoside-diphosphatase activity and also this GO :0017111 : nucleoside-triphosphatase activity, this GO :0005524 : ATP binding, this GO :0016787 : hydrolase activity, this GO :0017110 : nucleoside-diphosphatase activity, this GO :0017111 : nucleoside-triphosphatase activity, ectonucleoside triphosphate diphosphohydrolase 2 |
| Identity: |
3364 |
| Gene: |
ENTPD2 |
More about : ENTPD2 |
| Long gene name: |
ectonucleoside triphosphate diphosphohydrolase 2 |
| Synonyms gene: |
CD39L1 |
| Synonyms name: |
CD39-like-1 ecto-ATPase |
| Locus: |
9q34, 3 |
| Discovery year: |
1998-02-09 |
| GenBank acession: |
U91510 |
| Entrez gene record: |
954 |
| Pubmed identfication: |
9271669 |
| RefSeq identity: |
NM_203468 |
| Havana BLAST/BLAT: |
OTTHUMG00000020953 |